The global research and development (R&D) ecosystem is expanding rapidly, with $1.7 trillion invested worldwide. R&D now involves universities, companies, philanthropies, and nonprofits, not just governments. Scientific capabilities have advanced through artificial intelligence, open data, and worldwide collaboration, but the supporting systems are under stress.
To discuss these issues, the Karen Toffler Charitable Trust (KTCT) hosted a private Exeloop℠ dinner in Los Angeles on October 22, 2025, bringing together leaders from academia, philanthropy, industry, and government. The goal: to explore how research and innovation must evolve to meet society’s demands and how communities across sectors can mobilize collaboratively to shape that future.
A System Under Strain
Attendees began by noting that research now faces more constraints than before. Administrative tasks keep increasing, and compliance requirements take up much of scientists’ time. At the same time, government funding cuts, especially in neuroscience and biomedical research, are beginning to erode the foundation of early-stage research.
Several participants compared the current system to a body in survival mode. “The research ecosystem right now is fasting,” one guest observed. “Short-term restraint can bring focus, but over time, fasting turns to starvation.”
Without new investment, this 'fasting' will make it harder for young scientists and slow down promising innovations. As grants become harder to obtain, labs are forced to cut back, and early-career researchers may leave academia, with long-term effects.
The Collaboration Imperative
A major theme of the evening was the 'valley of death' in research translation, which is the gap between promising discoveries and their use in the clinic or marketplace. Labs generate data, but many innovations stall before they ever reach patients.
Industry was seen as essential for scaling, regulatory know-how, and commercialization. To tap this, stronger partnerships are needed among academia (idea generation), philanthropy (de-risking early work), and industry (market delivery).
Guests underscored the need to expand patient access to research, to ensure that the benefits of innovation reach communities earlier and more equitably. Direct patient community participation in data sharing, study design, and translational pathways was seen as a lever to accelerate adoption and impact.
Attendees highlighted the need for better intellectual property (IP) support for early-stage technology. Many young researchers lack guidance on IP, licensing, or partnerships. The group agreed that institutions should help investigators secure their work, establish clear agreements, and balance openness with value protection.
Technology and Transformation
Artificial intelligence (AI) emerged as a promising tool to accelerate discovery. Participants discussed how AI can quickly analyze large datasets to identify new uses for existing drugs. This could speed up development, reduce costs, and give new purpose to drugs that were previously set aside.
AI also enables personalized medicine, flexible trial designs, and international teamwork. However, these advances raise questions about data ethics and handling. As participants said, 'data openness must be balanced with data stewardship.' Future systems must support sharing while protecting privacy and IP.
Rethinking Philanthropy’s Role
The group spent a lot of time discussing both the potential and the limits of philanthropy.
Guests agreed philanthropy needs to be more flexible and open to experimentation, rather than acting like a bureaucracy or funding only safe projects. True risk-taking is rare, despite frequent discussion.
One participant summarized it plainly: “Philanthropy needs to dream with science—not just fund it.”
Attendees discussed how different types of philanthropy could work together. Institutional donors offer stability, credibility, and long-term support, while venture-style funds are more agile and can respond quickly. A hybrid approach could bring these strengths together, combining stability with the ability to take smart risks.
Philanthropy can help protect early-stage IP. Many young investigators need education to secure discoveries. Grants should provide IP training and legal support, empowering scientists and encouraging collaboration.
Transparency, Trust, and Public Understanding
Another key theme was the need for greater transparency in how research is funded and communicated. Donors often lack clear pathways to identify promising projects, and researchers struggle to connect with funders who align with their mission.
Participants proposed developing information-matching systems—digital platforms that link donor priorities with researcher proposals in real time while preserving confidentiality.
The conversation also highlighted the need for better public education. Most people do not really understand how research works, including its timelines, costs, risks, and effects on jobs and innovation.
As one guest said, “We can’t expect the public to support what it doesn’t understand.”
By showing how scientific investment creates new jobs, drives economic growth, and improves health, researchers and funders can help rebuild trust. Open communication about both successes and failures will be key to keeping the public engaged.
The Importance of New Methods of Collaboration
Participants agreed that advancing discovery in today’s interconnected world will require entirely new methods of collaboration. Traditional partnerships—formal grants, institutional consortia, or linear handoffs between academia and industry—are too slow for the pace of change. What is needed now are adaptive networks that enable scientists, clinicians, funders, and technology partners to exchange data, insight, and resources fluidly in real time. Such collaboration must be both structured and creative: supported by shared digital platforms, transparent data agreements, and mutual accountability, but also driven by curiosity and trust. These new models should make room for unconventional actors—patients, engineers, investors, and ethicists—whose participation can accelerate translation from discovery to application. In short, the future of research will belong to those who build living systems of collaboration that evolve as quickly as the science itself.
From Fasting to Flourishing
As the dinner ended, participants looked ahead. Most felt cautiously optimistic. The challenges are real, including funding gaps, slow-moving systems, and public doubt, but the group believed solutions are possible.
Attendees agreed coherence—aligning policy, funding, and purpose—is the goal. Governments must support basic science, philanthropies should take real risks, researchers should cross disciplines, and companies should see innovation as shared, not just competitive.
The main message: Without investment in people, infrastructure, and teamwork, progress will stall. But if funders, researchers, industry, and the public all step up, the potential is huge.
Three priorities emerged:
- Integration: Ensure that policies, funding streams, technologies, and data systems are actively coordinated among all sectors to strengthen the coherence of the research environment.
- Collaboration: Create multi-sector, multidisciplinary teams—including patients, funders, researchers, and industry—so that research benefits from a wide range of expertise and partnerships, resulting in more effective, scalable outcomes.
- Imagination: Foster a culture where philanthropists and researchers actively work together to identify and pursue novel and groundbreaking research opportunities.
About the Karen Toffler Charitable Trust
The Karen Toffler Charitable Trust (KTCT) is a 501(c)(3) nonprofit founded by futurists Alvin and Heidi Toffler in memory of their daughter Karen. KTCT supports early-career researchers working on new neuroscience projects and encourages collaboration among academia, industry, and philanthropy. Through programs such as the Toffler Scholars Program and the Exeloop series, KTCT carries on the Tofflers’ legacy of anticipation, imagination, and hope, advancing science and improving lives.